12,372 trials
Clear Cell Renal Cell Carcinoma
Primary: Sensitivity and Specificity of Qualitative Assessment of PET/CT Imaging With 89Zr-TLX250 to Noninvasively Detect ccRCC in Patients With Indeterminate Renal Masses, Using…
Influenza
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 23; 2 Participants
Mild Cognitive Impairment · Prodromal Alzheimer's Disease
Primary: Change in Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) Score From Baseline — 1.1; .9 score on a scale
Breast Cancer
Primary: ORR 24 — 71.1; 70.9 percentage of responders
Obesity · Overweight
Primary: Percent Change From Baseline in Body Weight — 3.3; -21.1 Percent change — p=<0.001
Short Bowel Syndrome
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 3 Participants
Seasonal Allergic Rhinitis
Primary: Area Under Curve (AUC) of the Total Nasal Symptoms Score (TNSS-3) — 16.96; 21.42 Sum of scores*hours — p=0.038
Myalgia
Primary: Myalgias Perceived at 3 Hours — 81; 83; 83; 15 Participants
Postmenopausal Women With Osteoporosis
Primary: Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Week 52 - Full Analysis Set (FAS) — 4.9597; 5.1528 percentage change (%)
Hemophilia B
Primary: Annualized Bleeding Rate (ABR) — 2.93 bleeding episodes per year
Partial Epilepsy
Primary: Summary of Treatment-Emergent Adverse Events (TEAEs) — 76; 35; 1104; 57 participants
Menorrhagia
Primary: Number of Participants With Successful Treatment of Heavy Menstrual Bleeding — 81; 83 Participants
Diabetes Mellitus
Primary: Number of Incident Diabetes-related ED Visits and/or Hospitalizations — .88; 1.29 Incidence rate ratio — p=.12
Rectal Cancer
Primary: Number of Participants Who Completed MSKCC Bowel Function Instrument (BFI Score) in Patients Following Anterior Resection (AR) or Sphincter Preserving Surgery (SPS) for…
Blood Clot · Trauma
Primary: Number of Participants With All-cause Mortality — 45; 47 Participants